Notable
Hybrid Individual and Group MDMA-assisted Therapy for War-related PTSD
Primary endpoint(s) modified
Also in this update: Study completion moved earlier from Dec 1, 2028 to Jul 1, 2028; Trial arms changed: 0 → 2
Guy SchusheimPhase 2 NCT05732155 Registry history of NCT05732155 on ClinicalTrials.gov (opens the registry)